PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 1, 1991British Journal of Pharmacology14 citationsOpen Access

Inhibitory effects of guanosine 3′: 5′‐cyclic monophosphate on the synthesis of dopamine in the rat kidney

View Full Paper
PSPatrı́cio Soares-da-SilvaMFMaria Helena Fernandes

Key Points

Key points are not available for this paper at this time.

Abstract

In the present study the effects of M the inhibitory effect of M&B 22,948 on DOPAC formation was greater than that on dopamine. 8-Bromo cyclic GMP (250 microM) produced only a slight decrease in the tissue levels of newly-formed dopamine (5-13% reduction), but was found to decrease significantly (51-68% reduction) the formation of DOPAC in kidney slices. The addition of 8-bromo cyclic GMP plus M&B 22,948 to the incubation medium resulted in similar effects to those described for M&B 22,948 alone. 4. In kidney homogenates, in contrast to results observed in kidney slices, M&B 22,948 (10 microM) and 8-bromo cyclic GMP (250 microM) were found to affect neither the formation of dopamine nor its deamination to DOPAC. 5. In conclusion, the results presented here suggest that cyclic GMP may be involved in the regulation of dopamine synthesis, probably through the control of the entry of L-DOPA into the tubular epithelial cells.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Soares-da-Silva et al. (1991) studied this question.

synapsesocial.com/papers/6a8541704b2893ddcbc6b57ehttps://doi.org/10.1111/j.1476-5381.1991.tb12353.x
Ask AI
Helpful
Bookmark
Share
View Full Paper